<?xml version='1.0' encoding='utf-8'?>
<document id="31172409"><sentence text="Potential drug interactions with antibacterials in long-term care facilities analyzed by two interaction checkers." /><sentence text="Background Residents in long-term care facilities take many medications concomitantly, including antibacterials, which increases the risk of drug-drug interactions" /><sentence text=" Objectives The aims of the study were to investigate the prevalence of severe potential interactions between antibacterials and other medications in Slovenian long-term care facilities and to compare the performance of two different drug-drug interaction checkers in these settings" /><sentence text=" Setting Residents in long-term care facilities in Slovenia" /><sentence text=" Method A point-prevalence study was conducted from April 2016 to June 2016" /><sentence text=" Residents' characteristics, antibacterial treatment, and concomitant medications were obtained from their medical charts" /><sentence text=" Potential drug-drug interactions were determined using Lexicomp Online™ 3" /><sentence text="0" /><sentence text="2 and the online Drugs" /><sentence text="com Drug Interactions Checker" /><sentence text=" The study only included potential drug-drug interactions categorized as type MA (major interactions) by the Drugs" /><sentence text="com checker and as type X (should be avoided) by Lexicomp Online™" /><sentence text=" The study calculated the differences in the number of type X and MA potential drug-drug interactions between different antibacterial classes and between the two drug-drug interactions checkers" /><sentence text=" Main outcome measure Number of medications per patient, number of potential drug-drug interactions with antibacterial, and differences between two drug-drug interactions checkers" /><sentence text=" Results Eighty (68" /><sentence text="4%) of Slovenian general long-term care facilities with 13,032 residents responded to the invitation" /><sentence text=" 317 (2" /><sentence text="4%) of the residents received antibacterial treatment and 212 residents were included in the analysis" /><sentence text=" On average, they received 10" /><sentence text="9 medications (SD = 3" /><sentence text="9)" /><sentence text=" Antibacterials were involved in 24" /><sentence text="1% type MA potential drug-drug interactions and 26" /><sentence text="4% type X potential drug-drug interactions" /><sentence text=" A significant difference in the total number of potential drug-drug interaction between the two checkers was found for all antibacterials, co-trimoxazole and fluoroquinolones (p &lt; 0"><entity charOffset="159-175" id="DDI-PubMed.31172409.s25.e0" text="fluoroquinolones" /></sentence><sentence text="005)" /><sentence text=" Type X and MA potential drug-drug interactions were more common with fluoroquinolones than with beta-lactams or co-trimoxazole (p &lt; 0"><entity charOffset="97-109" id="DDI-PubMed.31172409.s27.e0" text="beta-lactams" /><entity charOffset="113-127" id="DDI-PubMed.31172409.s27.e1" text="co-trimoxazole" /><pair ddi="false" e1="DDI-PubMed.31172409.s27.e0" e2="DDI-PubMed.31172409.s27.e0" /><pair ddi="false" e1="DDI-PubMed.31172409.s27.e0" e2="DDI-PubMed.31172409.s27.e1" /></sentence><sentence text="005)" /><sentence text=" Conclusion Potential interactions between antibacterials, especially fluoroquinolones and other drugs, were common in long-term care facility residents treated with antibacterials" /><sentence text=" Differences in the number of potential drug-drug interactions between the two checkers indicate that if available the use of several sources of information is recommended in clinical practice" /><sentence text=" The results call for a collaborative approach to address the risks of drug-drug interactions" /><sentence text="" /></document>